Metastatic pancreatic cancer is one of the most lethal cancers worldwide. Treatment options are very limited, particularly for older patients. A study led by the Pancreatic Cancer Unit of the Comprehensive Cancer Center (CCC) of MedUni Vienna and Vienna General Hospital has now shown that the combination of two chemotherapies (nab-paclitaxel and gemcitabine) works just as well in older patients as in younger ones and is well tolerated.
The work was published in the European Journal of Cancer. The CCC experts stress that the successful treatment of pancreatic cancer requires special expertise, which is why patients must be treated in specialist centres. Read more . . .